EpiBone

Last updated

EpiBone is a biomedical engineering company that is developing technology to create bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts. [1] [2]

Contents

History

EpiBone was founded in 2013 by Nina Tandon and Sarindr “Ik” Bhumiratana in New York City. [3] The company’s technology derives from research in bone and osteochondral tissue engineering at Columbia University. [4]

See also

References

  1. ↑ "This Woman's Revolutionary Startup Could Change 900,000 Surgeries A Year". Business Insider. Retrieved 2015-10-20.
  2. ↑ "EpiBone" . Retrieved 2022-04-07.
  3. ↑ "This Startup Wants People to Grow Their Own Bone Transplants". Bloomberg.com. Archived from the original on 2022-12-03. Retrieved 2025-09-07.
  4. ↑ Murphy, Sean V.; Atala, Anthony (2016). Regenerative Medicine Technology: On-a-Chip Applications for Disease Modeling, Drug Discovery and Personalized Medicine. CRC Press. p. 407. ISBN   9781498711920.
Meuble heraldique prothese de jambe.svg

This article about biomedical engineering is a stub. You can help Wikipedia by expanding it.

Factory.svg

This article about a corporation or company specializing in health technology is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.